Team Up with Aspreva

ASPREVA HAS PIONEERED A UNIQUE INDICATION EXPANSION APPROACH

Aspreva has pioneered a unique partnership model for pharmaceutical product expansion. Aspreva's strategy is innovative and simple - identify a late stage or already approved drug with the potential to treat new indications and supply the resources and expertise to allow our partners to extend the benefits of these products to patients living with less common diseases, without diverting resources from their core therapeutic areas.

By expanding research into less common diseases, Aspreva is able to effect rapid positive change for patients, while enhancing the lifecycle of existing drugs.

Benefits for Partners

For our partners, an Aspreva collaboration enhances their competitive profile, enables them to mitigate off-label risks, allows them to maintain control of their key assets, and gains them access to Aspreva's speed, innovation and expertise. For more information, please visit Partnering Benefits.

Our focus

Aspreva focuses on developing evidence-based medicines for diseases where there is a lack of adequate treatments and few, if any, treatments in development. Our expertise is in the effective management of all aspects of product development for these complex therapeutic categories, including clinical, regulatory and commercial development.

Aspreva is interested in considering late stage and already approved products. Each collaboration is designed to meet the needs of the individual company and brand, as well as leverage the strengths and resources of the partners.

We know that creating long-term productive relationships with our pharmaceutical partners and the medical communities we serve will help us fulfill our mission of helping patients who live with less common diseases.

For further information about Aspreva partnering opportunities, please contact us at BD@aspreva.com.